Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Persistence, transmission, and infectivity of SARS-CoV-2 in inanimate environments

ABSTRACT: Currently, the emergence of a novel coronavirus, referred to as SARS-CoV-2, has become a global health concern which cause severe respiratory tract infections in humans. Person-to-person transmission of SARS-CoV-2 has occurred across the globe, within a short period of SARS-CoV-2 emergence. The goal of this analysis is to summarize in various inanimate surfaces and environments information about the frequency, persistence, potential dissemination, and infectivity of SARS-CoV-2. Most respiratory viruses, including coronaviruses, SARS-CoVs, or influenza may persist for a few days on the surfaces or objects. The length of tenacity on various inanimate surfaces depends on the environmental and growth conditions and overall survival rate could range from minutes to month time. The SARS-CoV-2 may survive and maintain infectivity in the air in unventilated buses for 30 ?min. As no specific vaccines or therapeutic drugs are available for this contagious virus, timely prevention measures would be crucial to control the future outbreak of this infectious disease. Precautionary strategies such as wearing masks and frequent washing hands are effective to mitigate COVID-19. Following careful consideration of the above-mentioned scenarios, the short review spotlights the pressing environmental issues regarding the persistence, transmission, and infectivity of SARS-CoV-2 in different environmental matrices. Aiming to address this issue with further and deeper insight into the SARS-CoV-2 emergence, a list of most concerned questions is given that should be carefully considered and answered in future studies.

SUBMITTER: Bilal M

PROVIDER: S-EPMC7546641 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Infectivity of SARS-CoV-2 on Inanimate Surfaces: Don't Trust Ct Value.

Project description:SARS-CoV-2 RNA is frequently identified in patient rooms and it was speculated that the viral load quantified by PCR might correlate with infectivity of surfaces. To evaluate Ct values for the prediction of infectivity, we investigated contaminated surfaces and Ct-value changes after disinfection. Viral RNA was detected on 37 of 143 investigated surfaces of an ICU. However, virus isolation failed for surfaces with a high viral RNA load. Also, SARS-CoV-2 could not be cultivated from surfaces artificially contaminated with patient specimens. In order to evaluate the significance of Ct values more precisely, we used surrogate enveloped bacteriophage Φ6. A strong reduction in Φ6 was achieved by three different disinfection methods. Despite a strong reduction in viability almost no change in the Ct values was observed for UV-C and alcoholic surface disinfectant. Disinfection using ozone resulted in a lack of Φ6 recovery as well as a detectable shift in Ct values indicating strong degradation of the viral RNA. The observed lack of significant effects on the detectable viral RNA after effective disinfection suggest that quantitative PCR is not suitable for predicting the infectivity of SARS-CoV-2 on inanimate surfaces. Ct values should therefore not be considered as markers for infectivity in this context.

| S-EPMC9779331 | biostudies-literature

Interactions of SARS-CoV-2 with inanimate surfaces in built and transportation environments.

Project description:Understanding the interactions and transmission of pathogens with/via inanimate surfaces common in the built environment and public transport vehicles is critical to promoting sustainable and resilient urban development. Here, molecular dynamics (MD) simulations are used to study the adhesion of SARS-CoV-2 (the causative agent of COVID-19) to some of these surfaces at different temperatures (same for surfaces and ambiance) ranging from -23 to 60 °C. Surfaces simulated are aluminum, copper, copper oxide, polyethylene (PE), and silicon dioxide (SiO2). Steered MD (SMD) simulations are also used to investigate the transfer of the virus from PE and SiO2 when a contaminated surface is touched. The virus shows the lowest and highest adhesions to PE and SiO2, respectively (20 vs 534 eV). Influence of temperature is not found to be noticeable. Using simulated water molecules to represent moisture on the skin, SMD simulations show that water molecules can lift the virus from the PE surface but damage the virus when lifting it from the the SiO2 surface. The results suggest that the PE surface is a more favorable surface to transmit the virus than the other surfaces simulated in this study. The results are compared with those reported in a few experimental studies.

| S-EPMC9761300 | biostudies-literature

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.

Project description:We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California, a state in the western United States. Named B.1.427/B.1.429 to denote its two lineages, the variant emerged in May 2020 and increased from 0% to >50% of sequenced cases from September 2020 to January 2021, showing 18.6%-24% increased transmissibility relative to wild-type circulating strains. The variant carries three mutations in the spike protein, including an L452R substitution. We found 2-fold increased B.1.427/B.1.429 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation common to variants B.1.1.7, B.1.351, and P.1. Antibody neutralization assays revealed 4.0- to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California exhibiting decreased antibody neutralization warrants further investigation.

| S-EPMC8057738 | biostudies-literature

Contamination of inert surfaces by SARS-CoV-2: Persistence, stability and infectivity. A review.

Project description:Undoubtedly, there is a tremendous concern regarding the new viral strain "Severe Acute Respiratory Syndrome Coronavirus-2" (SARS-CoV-2) and its related disease known as COVID-19. The World Health Organization has stated that SARS-CoV-2 is mainly transmitted from person-to-person close contact, as well as by small aerosol respiratory droplets. Moreover, the results of some recent studies about the role of air pollution on the spread and lethality of the novel coronavirus suggest that air contaminants could be also a transmission pathway of the virus. On the other hand, indirect transmission of the virus cannot be discarded. Among many sources of indirect transmission, there is the contamination of inert/inanimate surfaces. This manuscript was aimed at reviewing the scientific literature currently available in PubMed and Scopus. The results of the reviewed studies point out that SARS-CoV-2 can last on different surfaces from hours to a few days. However, rapid SARS-CoV-2 inactivation is possible by applying commonly available chemicals and biocides on inanimate surfaces. Consequently, although the presence of SARS-CoV-2 on inanimate surfaces can represent a potential route of transmission, appropriate disinfection measures should reduce the possibilities of coronavirus transmission, and hence, significantly decrease the risks of COVID-19.

| S-EPMC7706414 | biostudies-literature

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces.

Project description: Not available

| S-EPMC7480442 | biostudies-literature

Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting.

Project description:Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is mainly transmitted through respiratory droplets, aerosols, or direct contact with fomites from an infected subject. It has been reported that SARS-CoV-2 is stable and viable in aerosol up to 16 h in controlled laboratory conditions. However, the aerosolization conditions varied a lot between the studies. In this work, an experimental laboratory model of SARS-CoV-2 aerosolization was established, employing an impinger nebulizer, a cylindrical chamber for aerosol travel, and a SKC biosampler for the collection of particles. The efficiency of the system was assessed based on the molecular determination of the viral load in the nebulizer after the aerosolization and in the aerosol collected at the end of the travel. Moreover, the residual infectivity was tested in vitro on the Vero E6 cell line, through the observation of the cytopathic effect (CPE), and the quantification of the viral load in the supernatants at 7 days post inoculation (dpi). A high RNA viral load was found in the SKC biosampler after aerosolization, indicating that it was possible to transport a high virus titer through the 30-cm chamber with all the dilutions (initial 105, 104, 103 plaque forming unit-PFU/mL). At the 7 dpi, an increment of the RNA viral load was determined for the dilutions 105 and 104 PFU/mL tested, while only the initial 105 PFU/mL resulted in visible CPE. Our findings allowed us to achieve the resilience of SARS-CoV-2 in aerosol form, at a concentration comparable to those reported for clinical samples. This mode of transmission should be considered for the mitigation and preventive measures to counteract SARS-CoV-2 spreading.

| S-EPMC8582643 | biostudies-literature

Mutations Strengthened SARS-CoV-2 Infectivity.

Project description:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity is a major concern in coronavirus disease 2019 (COVID-19) prevention and economic reopening. However, rigorous determination of SARS-CoV-2 infectivity is very difficult owing to its continuous evolution with over 10,000 single nucleotide polymorphisms (SNP) variants in many subtypes. We employ an algebraic topology-based machine learning model to quantitatively evaluate the binding free energy changes of SARS-CoV-2 spike glycoprotein (S protein) and host angiotensin-converting enzyme 2 receptor following mutations. We reveal that the SARS-CoV-2 virus becomes more infectious. Three out of six SARS-CoV-2 subtypes have become slightly more infectious, while the other three subtypes have significantly strengthened their infectivity. We also find that SARS-CoV-2 is slightly more infectious than SARS-CoV according to computed S protein-angiotensin-converting enzyme 2 binding free energy changes. Based on a systematic evaluation of all possible 3686 future mutations on the S protein receptor-binding domain, we show that most likely future mutations will make SARS-CoV-2 more infectious. Combining sequence alignment, probability analysis, and binding free energy calculation, we predict that a few residues on the receptor-binding motif, i.e., 452, 489, 500, 501, and 505, have high chances to mutate into significantly more infectious COVID-19 strains.

| S-EPMC7375973 | biostudies-literature

Intrauterine SARS-CoV-2 transmission

Project description:Hereby, we report a confirmed case of intrauterine SARS-CoV-2 transmission with rapid placental dysfunction and fetal distress.

| PRJEB40434 | ENA

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity.

Project description:We report cellular nanosponges as an effective medical countermeasure to the SARS-CoV-2 virus. Two types of cellular nanosponges are made of the plasma membranes derived from human lung epithelial type II cells or human macrophages. These nanosponges display the same protein receptors, both identified and unidentified, required by SARS-CoV-2 for cellular entry. It is shown that, following incubation with the nanosponges, SARS-CoV-2 is neutralized and unable to infect cells. Crucially, the nanosponge platform is agnostic to viral mutations and potentially viral species, as well. As long as the target of the virus remains the identified host cell, the nanosponges will be able to neutralize the virus.

| S-EPMC7301960 | biostudies-literature

Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.

Project description:Coronavirus disease (COVID-19) is a respiratory disease affecting many people and able to be transmitted through direct and perhaps indirect contact. Direct contact transmission, mediated by aerosols or droplets, is widely demonstrated, whereas indirect transmission is only supported by collateral evidence such as virus persistence on inanimate surfaces and data from other similar viruses. The present systematic review aims to estimate SARS-CoV-2 prevalence on inanimate surfaces, identifying risk levels according to surface characteristics. Data were obtained from studies in published papers collected from two databases (PubMed and Embase) with the last search on 1 September 2020. Included studies had to be papers in English, had to deal with coronavirus and had to consider inanimate surfaces in real settings. Studies were coded according to our assessment of the risk that the investigated surfaces could be contaminated by SARS-CoV-2. A meta-analysis and a metaregression were carried out to quantify virus RNA prevalence and to identify important factors driving differences among studies. Thirty-nine out of forty retrieved paper reported studies carried out in healthcare settings on the prevalence of virus RNA, five studies carry out also analyses through cell culture and six tested the viability of isolated viruses. Overall prevalences of SARS-CoV-2 RNA on high-, medium- and low-risk surfaces were 0.22 (CI95 [0.152-0.296]), 0.04 (CI95 [0.007-0.090]), and 0.00 (CI95 [0.00-0.019]), respectively. The duration surfaces were exposed to virus sources (patients) was the main factor explaining differences in prevalence.

| S-EPMC8313411 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data